Yes emerging technologies can pose risks - but regulation must focus on outcomes of the technology, not the technology itself.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai CRISPR/Cas9
Menampilkan 41 - 60 dari 69 artikel
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
One big challenge for gene therapies is delivering DNA or RNA safely to cells inside patients’ bodies. New nanoparticles could be an improvement over the current standard – repurposed viruses.
A new gene editing experiment explores human development. With this comes new ethical questions: How do scientists acquire embryos and how are their projects approved?
A landmark study in the UK discovered the gene that allows cells to form into embryos. If Australian researchers attempted this they could go to jail for 15 years.
Americans have moved on from worrying about ‘test-tube babies’ – but there are still ethical challenges to resolve as reproductive technologies continue to advance.
A team in the U.S. is said to have safely and effectively altered human embryos. The news is a reminder that citizens must be consulted on developments potentially affecting the future of the species.
The news may have come as a surprise, but it probably shouldn’t have. A bioethics expert walks through how big a deal this announcement is – and what we should be considering now.
Simple and inexpensive gene-editing technology such as CRISPR has made the creation of genetically modified organisms much easier. But could nature still keep the upper hand?
William Isdale speaks with University of Queensland Professor Peter Koopman about CRISPR technology.
A new research paper reports dangerous side effects in CRISPR-edited mice. Some scientists are pushing back, placing blame for the unwanted mutations on the experiment, not the technique.
A new report from the National Academies of Science and Medicine outlines conditions that have to be met before gene editing that results in heritable genomic changes can be considered.
A report released by the US National Academies of Science and Medicine underscores the potential of gene editing and acknowledges the sensitivities in managing the ethical dimensions.
It’s possible to alter the make-up of a species such as a mosquito’s ability to pass on the deadly malaria parasite. But we need to consider the pros and cons of such gene editing technology.
Medical tourism for assisted reproductive technologies raises a host of legal and ethical questions.
Controversy over a Chinese study that used CRISPR-Cas9 gene-editing technology shows how the West still looks at the East through the lens of Orientalism.
Regulations, funding and public opinion around genetically enhancing future generations vary from country to country. Here’s why China may be poised to be the pioneer.
U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there’s a lot more at stake than just who gets the credit and licensing fees.
The concerns about genetically modified foods are well known. But when we look at population and climate projections, what happens if we don’t use them to increase our food supply?
New research suggests how we could prevent genetically modified organisms from surviving - and potentially spreading - in the wild.
Kontributor teratas
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Associate professor, Queensland University of Technology
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Shah Rising Star Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Professor of Chemistry, Connecticut College
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Doctoral Student in Biochemistry, University of Washington
-
Postdoctoral Associate in Science and Society, Duke University
-
Director of Research and Professor of Pathology, Dalhousie University
-
Professor of Molecular Genetics and Microbiology, University of Florida
-
Lecturer in Philosophy of Science, University of Sydney
-
Senior Research Fellow, King's College London
